Short Interest in Aptorum Group Limited (NASDAQ:APM) Increases By 41.8%

Aptorum Group Limited (NASDAQ:APM) saw a large increase in short interest during the month of February. As of February 15th, there was short interest totalling 115,400 shares, an increase of 41.8% from the January 31st total of 81,400 shares. Based on an average daily volume of 2,250,000 shares, the short-interest ratio is presently 0.1 days. Currently, 2.5% of the shares of the company are sold short.

Aptorum Group Trading Up 4.8 %

Aptorum Group stock opened at $0.93 on Wednesday. Aptorum Group has a 12 month low of $0.46 and a 12 month high of $17.49. The business’s 50 day simple moving average is $1.29 and its 200 day simple moving average is $1.55.

About Aptorum Group

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.